LEAD Therapeutics, Inc. is a chemistry-driven small molecule drug discovery company. Its goal is to develop a continual supply of novel and differentiated high-quality IND candidates in key therapeutic areas where the need for improvement is the greatest. By leveraging the best of the US and China, and through judicious target selection, LEAD plans to deliver a pipeline of drug candidates in a capital and time-efficient manner.

Headquartered in the San Francisco Bay Area, LEAD Therapeutics is led by an experienced small molecule drug discovery team with proven track records in the pharmaceutical and biotech industries. The company will carry out the majority of its discovery research activities in China, and has several drug discovery programs on-going in infectious diseases and oncology.